Antiviral Nucleotide Incorporation by Recombinant Human Mitochondrial RNA Polymerase Is Predictive of Increased In Vivo Mitochondrial Toxicity Risk.
about
Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA Polymerase.Simple In Vitro Assay To Evaluate the Incorporation Efficiency of Ribonucleotide Analog 5'-Triphosphates into RNA by Human Mitochondrial DNA-Dependent RNA Polymerase.Addressing the selectivity and toxicity of antiviral nucleosides.
P2860
Antiviral Nucleotide Incorporation by Recombinant Human Mitochondrial RNA Polymerase Is Predictive of Increased In Vivo Mitochondrial Toxicity Risk.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiviral Nucleotide Incorpora ...... o Mitochondrial Toxicity Risk.
@en
Antiviral Nucleotide Incorpora ...... o Mitochondrial Toxicity Risk.
@nl
type
label
Antiviral Nucleotide Incorpora ...... o Mitochondrial Toxicity Risk.
@en
Antiviral Nucleotide Incorpora ...... o Mitochondrial Toxicity Risk.
@nl
prefLabel
Antiviral Nucleotide Incorpora ...... o Mitochondrial Toxicity Risk.
@en
Antiviral Nucleotide Incorpora ...... o Mitochondrial Toxicity Risk.
@nl
P2093
P2860
P356
P1476
Antiviral Nucleotide Incorpora ...... vo Mitochondrial Toxicity Risk
@en
P2093
Alexandre Catoire
Christopher Jones
Fumiaki Yokokawa
Heinz Moser
Julie Boisclair
Kathryn Bracken
Keith Mansfield
Kyoko Uehara
P2860
P304
P356
10.1128/AAC.01253-16
P407
P577
2016-11-21T00:00:00Z